CSL Limited (CMXHF) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the CSL Limited full year financial results. All participants are in a listen only mode. There will be a presentation followed by a question and answer session. If you wish to ask a question, you will need to press the star key followed by the number one on your telephone keypad. I would now like to hand the conference over to Mr. Chris Cooper, Head of Investor Relations. Please go ahead. Good morning and welcome to CSL's full year results call for fiscal 2025. It's Chris Cooper speaking and I'm pleased to be joined by Paul McKenzie, CSL's Chief Executive Officer and Joy Linton, CSL's Chief Financial Officer. As with past practice, Paul will provide an overview of the results and then Joy will provide additional detail on the financials. We'll then move to Q&A. Please note this briefing is being webcast and before we start, I draw your attention to the forward statement disclaimer contained in the slide deck. I'll now hand over to CSL's Chief Executive Officer, Dr. Paul McKenzie. Thank you, Chris. Good morning. I am Paul McKenzie, CSL's Chief Executive Officer and Managing Director. Today, I will highlight our business performance for fiscal year 25 and provide some comments on our strategy to deliver enduring impact for our patients and shareholders. CSL's Chief Financial Officer, Joy Linton, will then take you through our financials. I will then provide more detail around our transformation initiatives and simplification announcements before closing with our outlook and guidance for financial year 2026. We will then take your questions. You have seen that CSL has made key announcements today that I believe will drive growth for the company into the future. Growth was once again a key feature of our results for fiscal year 25...